Global Pills Market Share Is currently worth USD 1,800 million. Furthermore, the market is expected to demonstrate a robust CAGR of 14.2% during the forecast period (2018–2023).
Pills Market Share Overview
The smart pills are mostly found in the form of a vitamin capsule sized pill, containing a small wearable sensor patch, in addition to an application on mobiles as well as a provider portal. After swallowing a smart pill, its activation in the gut occurs; after which the sensors offer information with regard to the patient’s health parameters coupled with the effectiveness of the treatment.
Smart pills refer to the capsule-sized medical devices that are ingestible and contain elements like cameras, sensors, trackers, and patches. These devices are used for improved diagnostics along with patient monitoring and targeted drug delivery.
Leading Companies
The leading companies within the worldwide Pills Market Share include,
- CapsoVision Inc.
- MEDTRONIC
- FUJIFILM Holdings Corporation
- Proteus Digital Health Inc.
- Olympus Corporation
- BDD Limited
- Check-Cap
- JINSHAN Science & Technology
- PENTAX Medical
- MEDISAFE
- RF Co. Ltd.
- among others.
Avail Free Sample of Smart pills are also considered to be a revolutionary aspect in the field of gastrointestinal diagnosis. Due to being non-invasive, smart pills are touted to be a compelling alternative approach compared to the invasive procedures including colonoscopy/ gastrointestinal endoscopy.
Browse Complete Premium Research Page along with Detailed TOC@ https://www.marketresearchfuture.com/reports/smart-pills-market-6591
Pills Market Share Segmentation
The worldwide Pills Market Share is segmented based on application, target area, disease indication, and end-user.
With respect to the application, the market has been segmented into capsule endoscopy, drug delivery, patient monitoring, and others. The types of capsule endoscopy are small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. The types of patient monitoring include capsule pH monitoring and others.
depending on the target area, has been categorized into esophagus, small intestine, large intestine, and stomach.
The disease indication section has been considered for esophageal diseases, small bowel diseases, colon diseases, and others.
The end-users covered by the report are hospitals, diagnostic center, and research institute.
At Market Research Future (MRFR), Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
+1 646 845 9312
Email: sales@marketresearchfuture.com
Global Contraceptive pills Market - OverviewAnti-conception medication pills which are also called as oral contraceptive pills are a kind of female hormonal anti-conception medication technique and are extremely viable at avoiding pregnancy.
These pills are small tablets that a patient swallow every day.
These birth control pills are been used from ancient times but the save and effective methods are introducing and available from 20th century.
Governmental initiatives for minimizing unwanted pregnancy, increasing awareness and healthcare expenditure, and increasing in use of contraceptives drugs has provided fuel for the growth of the market.
According to a recent study report published by the Market Research Future, the global contraceptive pills market is booming and expected to gain eminence over the forecast period.
North America contraceptives drug market is expected to grow at a CAGR of 5.9 % during forecasted period.Global Contraceptive pills Market - Competitive AnalysisMerck & Co., Inc (US), Pfizer Inc (US), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), Allergan plc.
The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period.
High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market.
Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas.
This will effectively accelerate the oral contraceptives market growth during the forecast period.Expeditious Need to Curb Population Growth to Feed Market DevelopmentAccording to the United Nations’ Department of Economic and Social Affairs, by 2030, world population will reach 8.6 billion and by 2050, it will be 9.8 billion.
Proactive measures are being taken by governments across the globe about family planning and use of the contraceptives to avoid unnecessary pregnancies.
Furthermore, increasing prevalence of teenage pregnancies, particularly in the U.S. has also emerged as a central factor driving the growth of this market.Increasing Popularity of Advanced Contraceptives to Propel the Market in North AmericaNorth America is slated to dominate the contraceptive pills market share, since the region generated USD 4.09 billion in revenue in 2018.
